Optimizing Immunosuppression in Liver Transplant Recipients


001 - Overview of immunosuppression in liver transplant recipients


Description

After participating in this activity, the learner will be able to:

  • Identify the mechanisms of action of the main immunosuppression therapies used in liver transplantation.
  • Discuss the use of specific induction and maintenance agents by liver transplant programs over time.
  • Explain therapeutic drug monitoring of immunosuppression therapies and the general approach to monitoring immunosuppression in liver transplant recipients.

Speaker(s):

  • Josh Levitsky, MD, MS, Northwestern University Feinberg School of Medicine

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content
token-speaker-name image
token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content